Ignite Creation Date:
2024-05-06 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 12:48 PM
Study NCT ID:
NCT03564197
Status:
RECRUITING
Last Update Posted:
2023-10-18
First Post:
2018-04-11
Brief Title:
18F-PD-L1 PETCT in Nivolumab Treated Patients With NSCLC
Sponsor:
The Netherlands Cancer Institute
Organization:
The Netherlands Cancer Institute
Organization Data
Organization:
The Netherlands Cancer Institute
Class:
OTHER
Study ID:
M17FNN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Netherlands Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |